Tagged with Mexico

Mexico Maarten Pouw, business unit director of Mexico and Latin America at DSM Sinochem Pharmaceuticals, explains the crucial role that sustainable antibiotics play in combating antimicrobial resistance and showcases the company’s region-wide commitment to offering reliable, compliant and sustainable APIs. Could you please introduce to our international audience the key activities…

Mexico GM Gerardo Torres-Septién explains how Grupo Rasch has managed to grow during the last two years and showcases the added value of its solutions to help the pharmaceutical industry enhance its cost structure and efficiency ratios. Could you please give an update to our international audience about the operations and…

Mexico Juan Francisco Hernández, general manager of Latin America at Wockhardt, showcases the added value of the company to the entire region based on quality, safety and cost-effective medicines targeting diabetes, CNS and anti-infective areas. Could you introduce yourself to our international readers as well as the key activities and operations…

Mexico María Teresa Lopez, managing director at Zimmer Biomet Mexico, discusses the medtech company’s strong commitment to Mexico as well as the high added value of its broad and innovative health solutions to enhance patients’ quality of life. Please introduce the main activities of Zimmer Biomet in Mexico and the Mexican…

Mexico Alberto Wicker, CEO at Signufarma, explains how patient compliance programs can enhance the national healthcare system through reducing the cost of treatment as well as improving patients’ quality of life and showcases the added value of Signufarma’s business solutions to enhance the medical compliance of Mexican patients. Could you please…

Mexico Ricardo Amtmann, President at Laboratorios Sanfer, explains how they have grown their business by 100 percent throughout the last three years and showcases the added value of Sanfer to patients in Mexico and internationally by offering high quality drugs and boosting the sales of in-licensed medicines. Could you introduce yourself…

Mexico Patricia López, general manager at seca Mexico, showcases the added value of seca’s product portfolio and explains that interconnectivity should be medical devices’ path of development; generating benefits for patients, physicians and government. Could you please update our international readers on the operations of seca in Mexico? “Latin America has…

Mexico Patrick Troop, CEO at Pharma Tycsa, explains the company’s unique business approach in Mexico developing “clinical pharmacies” model to address chronic diseases treatment in the points of care and the importance of public and private partnerships to enhance the national health system. Could you please introduce to our international the…

Mexico Victor Manuel Fernández Navarro, CEO at Vicma, explains how strategically important is to have a healthy business model in the distribution industry through sustainable collection period, attractive profit margins and diversified clients’ portfolio. Additionally, he showcases the value proposition of Vicma to successfully distribute high quality medicines to remote areas…

Mexico Dr. Marco A. Martinez Rios, General Director of the National Institute of Cardiology in Mexico elaborates on the institution’s rich history in Mexico and its contributions to cardiology through research, teaching and treatment. As the general director of the National Institute of Cardiology, could you introduce yourself to our international…

Mexico Andrés Matesanz, general manager at DCS Pharma Mexico, explains how the merger between Dolder and Chemswiss has enlarged the capabilities and the offering of the company in Mexico and showcases the added value of DCS Pharma being considered the fastest option within the industry. ChemSwiss has recently merged with Dolder.…

Mexico José Alberto Peña, managing director at Marzam Mexico, showcases the benefits that distributors can offer to the healthcare and life science sector as well as Marzam’s strategy to overcome the industry challenges in Mexico. After twenty-five years working for some of the most prestigious pharmaceutical companies you accepted in November…